Tendering of Biosimilars | Insights from the Biosimilars Global Congress, 2022 Europe

Nov 08, 2022

The Biosimilars market in Europe, as well as globally, will continue to grow significantly over the coming years. Tendering & Contracting is the main procurement mechanism for Biosimilars.
A solid understanding of the tender biosimilar market combined with the application of optimal tendering practices are critical for long-term success.

Nico Bacharidis, Business advisor of Cube RM, participated at the 14th Biosimilars Global Congress, an event that covers a diverse range of topics on Biosimilars, presenting an overview of the Biosimilar tender market and all the key success factors of Tendering in this specific sector.

You can download the full deck by filling your details in the form below.

    SHOW DOWNLOAD LINK

    Keep Reading

    Net Pricing Pharma | Cube RM

    ARTICLES

    PRICING INSIGHTS

    Net Pricing in Pharma & Award Criteria: The key ingredients in Pharma pricing strategy

    ARTICLES

    TENDER MANAGEMENT

    Mastering pharmaceutical tenders: top 5 challenges in Tender Management and what to do about them.

    WHITEPAPERS

    TENDER MARKET INTELLIGENCE

    TENDER MANAGEMENT

    The shift toward sustainability in pharmaceutical procurement and why ESG criteria in tendering is no longer optional.
    ALL NEWS